A detailed history of Cibc World Market Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Cibc World Market Inc. holds 25,300 shares of RPRX stock, worth $642,620. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,300
Previous 23,647 6.99%
Holding current value
$642,620
Previous $624,000 14.74%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$25.63 - $29.27 $42,366 - $48,383
1,653 Added 6.99%
25,300 $716,000
Q2 2024

Aug 07, 2024

BUY
$26.26 - $29.9 $207,322 - $236,060
7,895 Added 50.12%
23,647 $624,000
Q1 2024

May 13, 2024

BUY
$27.46 - $31.33 $432,549 - $493,510
15,752 New
15,752 $478,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.1B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.